标题
CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-04
DOI
10.3389/fimmu.2020.626820
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HMGB1 in Systemic Lupus Erythematosus
- (2020) Tianye Liu et al. Frontiers in Immunology
- Mapping systemic lupus erythematosus heterogeneity at the single-cell level
- (2020) Djamel Nehar-Belaid et al. NATURE IMMUNOLOGY
- New insights into the role of antinuclear antibodies in systemic lupus erythematosus
- (2020) David S. Pisetsky et al. Nature Reviews Rheumatology
- B cell checkpoints in autoimmune rheumatic diseases
- (2019) Samuel J. S. Rubin et al. Nature Reviews Rheumatology
- Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
- (2019) Sarah Y. Weißenberg et al. Frontiers in Immunology
- Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52
- (2019) Abdulrahman M. Shathili et al. Frontiers in Immunology
- B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
- (2019) Desmond Y. H. Yap et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy
- (2019) Corinne E. Decker et al. Scientific Reports
- CD4 + CD52 lo T-cell expression contributes to the development of systemic lupus erythematosus
- (2018) Masataka Umeda et al. CLINICAL IMMUNOLOGY
- CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function
- (2018) Esther Bandala-Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
- (2017) Tanvi Arkatkar et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy
- (2017) Aiden Haghikia et al. LANCET NEUROLOGY
- CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking
- (2016) A. Wiener et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- New insights into the immunopathogenesis of systemic lupus erythematosus
- (2016) George C. Tsokos et al. Nature Reviews Rheumatology
- Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
- (2016) Tilman Schlothauer et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus
- (2014) X.-n. Wu et al. Science Translational Medicine
- Immunopathogenic mechanisms of systemic autoimmune disease
- (2013) Marie Wahren-Herlenius et al. LANCET
- T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10
- (2013) Esther Bandala-Sanchez et al. NATURE IMMUNOLOGY
- Germinal Centers
- (2012) Gabriel D. Victora et al. Annual Review of Immunology
- The N-linked carbohydrate moiety of male reproductive tract CD52 (mrt-CD52) interferes with the complement system via binding to C1q
- (2012) Lutfi Hardiyanto et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
- (2012) Sambasiva P. Rao et al. PLoS One
- Selective and programmed cleavage of GPI-anchored proteins from the surface membrane by phospholipase C
- (2011) Alexandra Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Anergic Responses Characterize a Large Fraction of Human Autoreactive Naive B Cells Expressing Low Levels of Surface IgM
- (2011) T. D. Quach et al. JOURNAL OF IMMUNOLOGY
- CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression
- (2011) Y Saito et al. LEUKEMIA
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Copy number variations of Interleukin-12B and T-bet are associated with systemic lupus erythematosus
- (2011) Bo Yu et al. RHEUMATOLOGY
- Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questi
- (2011) Juanita Romero-Diaz et al. ARTHRITIS CARE & RESEARCH
- Mechanisms of B cell autoimmunity in SLE
- (2011) Thomas Dörner et al. ARTHRITIS RESEARCH & THERAPY
- Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus
- (2010) Andrew Wang et al. ARTHRITIS AND RHEUMATISM
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- A polymorphism withinIL21Rconfers risk for systemic lupus erythematosus
- (2009) Ryan Webb et al. ARTHRITIS AND RHEUMATISM
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
- (2009) Joanne L. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started